Active Ingredient (In Each Softgel)
Bismuth subsalicylate 262 mg
The following Structured Product Label (SPL) was submitted to the FDA by Softgel Healthcare Pvt Ltd for the product Bismuth Subsalicylate (NDC 35916-0234). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each softgel), purpose, uses, warnings reye’s syndrome:, allergy alert:, do not use if, ask a doctor before use if you have, ask a doctor or pharmacist before use if you are, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Bismuth subsalicylate 262 mg
Upset stomach reliever and antidiarrheal
relieves
Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign Reye’s syndrome, a rare but serious illness.
Contains salicylate. Do not take if you are
you have
taking any drug for
a temporary, but harmless, darkening of the stool and/or tongue may occur
ask a health professional before use
In case of overdose, get medical help or contact a Poison Control Center right away.
* Please review the disclaimer below.